|
Home
Products
Ordering
Information:
How
to Order
Distributors
Translations
For
Students or Training Programs
Site
and Scoring Licenses
Information
for Parents
Samples
of Forms
Multicultural
Applications
Reliability
and Validity
Information
for:
Preschool
(CBCL, C-TRF, TOF)
School-Age
(CBCL, TRF, YSR, SCICA, TOF,
DOF)
Adults
(ABCL, ASR)
Older
Adults (OABCL, OASR)
Software
(ADM, Web-Link,
iForms, WebForms
Direct, RTS, A2S)
Bibliography
Research:
About
Us:
ASEBA
Overview
ASEBA
Origins
ASEBA
Later Developments
ASEBA
Recent Advances
Support:
FAQs
Join
Listserv
Holiday
Schedule
Contact
Us
News
|
Posted
January, 2007
Effects
of Syndrome Co-Occurrence (Comorbidity) on Treatment Outcomes
"Comorbidity"
(the occurrence of two or more disorders in the same individual)
has been a popular topic since it was discovered that many
individuals meet DSM criteria for multiple disorders. Efforts
to develop and evaluate treatments focused on particular childhood
disorders, such as ADHD, have been greatly complicated by
the difficulty of finding enough children who have only the
target disorder without symptoms of other disorders. It has
been widely hypothesized that comorbidity may undermine the
effectiveness of treatments designed for particular disorders.
However, this hypothesis has not been well tested. One obstacle
to testing the effects of comorbidity on treatment outcome
is the difficulty of recruiting (a) groups of
children who meet DSM criteria for a particular target disorder
without other disorders and (b) comparison groups
of children who meet DSM criteria for the target disorder,
plus certain other disorders. To overcome this obstacle, Doss
and Weisz (2006) used scores on CBCL syndromes to test the
degree to which "co-occurring syndromes" affected
the outcomes for 325 7- to 17-year-olds treated in six California
mental health clinics. Pre-treatment and post-treatment CBCL
scores were subjected to hierarchical linear modeling (HLM)
analyses that took account of differences among therapists,
length of treatment, initial CBCL scores, and the co-occurrence
of scores among different syndromes. The HLM analyses showed
that co-occurring syndrome scores had negligible effects on
outcomes. In other words, contrary to the hypothesis that
comorbidity would undermine the effectiveness of treatment,
co-occurring syndromes did not result in poorer outcomes.
Instead, the initial scores on each syndrome were the best
predictors of outcomes for that syndrome. Doss and Weisz concluded
that "in general, co-occurrence did not seem to impact
usual care outcomes over and above the effects of initial
severity" (p. 424). They also concluded that the "dimensional
approach has several theoretical and statistical advantages
over traditional categorical approaches" (p. 424) to
assessing psychopathology and comorbidity.
Reference: Doss, A.J., & Weisz, J.R. (2006).
Syndrome co-occurrence and treatment outcomes in youth mental
health clinics. Journal of Consulting and Clinical Psychology,
74, 416-425.
|